Glaxo loses patent on Ranbaxy plea
A US federal court has invalidated Glaxo SmithKline Plc's patent for the antibiotic, Augmentin, clearing the way for introducing its low cost versions in the US, the world's largest market for
A US federal court has invalidated Glaxo SmithKline Plc's patent for the antibiotic, Augmentin, clearing the way for introducing its low cost versions in the US, the world's largest market for